temozolomide has been researched along with mevalonic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, X; Fang, C; Hong, B; Jiang, T; Kang, C; Li, G; Tan, Y; Tong, F; Wang, H; Wang, Q; Wang, Y; Xiao, M; Yang, C; Yang, S; Yi, K; Zhan, Q; Zhao, J; Zhou, J | 1 |
1 other study(ies) available for temozolomide and mevalonic acid
| Article | Year |
|---|---|
Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma.
Topics: Animals; Cell Line, Tumor; Energy Metabolism; ErbB Receptors; Fatty Acids; Glioblastoma; Ligases; Mevalonic Acid; Proto-Oncogene Proteins c-akt; Temozolomide | 2023 |